Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy
Keywords:toxic epidermal necrolysis, apalutamide, etanercept, steroid, tumour necrosis factor α
Abstract is missing (Short communication)
Endo Y, Oka A, Uehara A, Toki S, Motegi SI, Ishikawa O, et al. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug. J Dermatol 2020; 47: e359-e360.
Sagawa N, Watanabe Y, Mizuno Y, Takahashi S, Watanabe T, Ikeda N, et al. A case of toxic epidermal necrolysis associated with apalutamide administration. J Cutan Immunol Allergy 2020; 3: 134-135.
Miyagawa A, Adachi T, Kobayashi Y, Takamiyagi S, Arakawa H, Futatsugi K, et al. Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis. J Dermatol 2022; 49: e102-e103
Umemura H, Koroki Y, Iwaki Y, Imanaka K, Kamabara T, Lopez-Gitlitz A, et al. Skin rash following administration of apalutamide in Japanese patients with advanced prostate cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study. BMC Urology 2020; 20: 139.
Paradisi A, Abeni D, Bergamo F, Ricci F, Didona D, Didona B. Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol 2014; 71: 278-283.
Chang J, Girgis L. Clinical use of anti-TNF-α biological agents A: a guide for GPs. Aust Fam Physician 2007; 36: 1035-1038.
How to Cite
Copyright (c) 2022 Kana Osawa, Yukiko Kiniwa, Yuzuki Shimosato, Hirotaka Midorikawa, Takushi Shirai, Tasuku Sano, Kenta Nakamura, Ryuhei Okuyama
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.